26 reports

  • Introduction
  • ANGINA PECTORIS MARKET IN APAC

About Angina Pectoris Drugs Angina is a type of chest pain or discomfort caused due to a coronary heart disease, specifically due to reduced blood flow to the heart. For angina pectoris drugs market, beta blockers remain the most preferred line of treatment. However, the treatment market witnesses a strong presence of other drug...

  • Angina
  • Beta-Blocker
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG

Angina (Angina Pectoris) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ##.

  • Angina
  • United States
  • World
  • Demand
  • Product Initiative

Current European and North American guidelines advise continuing dual antiplatelet therapy for ## year following an acute coronary syndrome.

  • Angina
  • APAC
  • North America
  • World
  • Market Size
  • Prevalence of angina pectoris, females (000s)
  • Prevalence of angina pectoris, males (000s)

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Angina Pectoris in 20 Major Markets Angina Pectoris (AP) is the term given to the pain or discomfort felt when the heart muscle lacks an adequate supply of oxygen rich blood (ischaemia). The main cause of angina is coronary arterial disease (CAD), which...

  • Angina
  • Chronic Disease
  • Pathology

Angina Pectoris Drugs Market Analysis, By Therapeutic Class, By Major Markets And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ##.

  • Angina
  • United States
  • Forecast

Angina (Angina Pectoris) - Epidemiology Forecast to 2027 ##.

  • Angina
  • France
  • Germany
  • Italy
  • Spain

Drug A: Company ## ##. ##. ##.

  • Angina
  • Chronic Disease
  • Pathology
  • United States
  • Market Shares
  • DISEASE DEFINITION
  • NITRATES

About Coronary Artery Disease Therapeutics Coronary artery disease (CAD) is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries...

  • Angina
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Dormant Projects

Angina (Angina Pectoris) - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H2 2018, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape. Angina...

  • Angina
  • Cardiovascular Disease
  • Therapy
  • United States
  • Product Initiative
  • REFRACTORY ANGINA THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2018*
  • REFRACTORY ANGINA THERAPEUTICS, E7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2018*

Refractory Angina Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Refractory Angina Global Clinical Trials Review, H1, 2018" provides an overview of Refractory Angina clinical trials scenario.This report provides top line data relating to the clinical trials on...

  • Angina
  • Chronic Disease
  • World
  • Product Initiative
  • Les Laboratoires Servier SAS
  • CHRONIC STABLE ANGINA THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*
  • CHRONIC STABLE ANGINA THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY TRIAL STATUS, 2017*

Chronic Stable Angina Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic...

  • Angina
  • Therapy
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Therapeutics Development

Angina (Angina Pectoris) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H1 2018, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape. Angina...

  • Angina
  • Cardiovascular Disease
  • Therapy
  • United States
  • Product Initiative
  • Chronic Stable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Chronic Stable Angina Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Chronic Stable Angina Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, H2, 2016" provides an overview of Chronic Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic...

  • Angina
  • Chronic Disease
  • Therapy
  • World
  • Product Initiative

The report focuses on drugs and therapies being evaluated for Angina (Angina Pectoris) treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Pathology

Insights into Angina (Angina Pectoris) Pipeline ##.

  • Angina
  • Chronic Disease
  • Pathology
  • World

The report focuses on drugs and therapies being evaluated for Stable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Discovery And Development

The report focuses on drugs and therapies being evaluated for Vasospastic Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Discovery And Development
  • Pathology

The report focuses on drugs and therapies being evaluated for Refractory Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Discovery And Development
  • Pathology

The report focuses on drugs and therapies being evaluated for Unstable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Discovery And Development

The report focuses on drugs and therapies being evaluated for Chronic Stable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Discovery And Development
  • Vasospastic Angina Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Vasospastic Angina Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Vasospastic Angina Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Vasospastic Angina Global Clinical Trials Review, H2, 2016" provides an overview of Vasospastic Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Vasospastic Angina....

  • Angina
  • Cardiovascular Drug
  • Chronic Disease
  • World
  • Product Initiative
  • Refractory Angina Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Refractory Angina Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Refractory Angina Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Refractory Angina Global Clinical Trials Review, H2, 2016" provides an overview of Refractory Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Refractory Angina. Report...

  • Angina
  • Chronic Disease
  • Pathology
  • World
  • Product Initiative
  • Stable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Stable Angina Therapeutics, Global, Clinical Trials by Trial Status, 2016*

Stable Angina Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Stable Angina Global Clinical Trials Review, H2, 2016" provides an overview of Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Stable Angina. Report includes an...

  • Angina
  • Cardiovascular Disease
  • Therapy
  • World
  • Product Initiative
  • Unstable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Unstable Angina Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*

Unstable Angina Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Unstable Angina Global Clinical Trials Review, H2, 2016" provides an overview of Unstable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Unstable Angina. Report includes...

  • Angina
  • Cardiovascular Disease
  • Therapy
  • World
  • Product Initiative

Angina (Angina Pectoris) - Pipeline Insight, 2018 ##.

  • Angina
  • Chronic Disease
  • Pathology

2018 Angina Pectoris Or Ischemic Chest Pain Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Angina Pectoris Or Ischemic Chest Pain Market ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Angina Pecto

  • Angina
  • Chronic Disease
  • Pathology